Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA)

Authors :: Thomas C. Smyrk
Susan M. Harrington
Robert R. McWilliams
Katrina Pedersen
Source :: Journal of Clinical Oncology. 33:3619-3619
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 3619 Background: SBAs are rare, resulting in a paucity of data on effective treatments. Highly active immune surveillance within all parts of the intestine may explain the rarity. In such an enviro...

Subjects :: Cancer Research
Oncology
business.industry
Cancer research
Medicine
Pd l1 expression
Ligand (biochemistry)
business
Immune surveillance
Programmed death

Full Text Access

Tools